A similar company, Valeant bought drug companies, raised prices and slashed R&D. Bid for Allergan Puts Valeant's Research and Development Cuts Under Scrutiny $

A similar company, Valeant bought drug companies, raised prices and slashed R&D. Bid for Allergan Puts Valeant's Research and Development Cuts Under Scrutiny $53 Billion Bid Puts Focus on Strategy of Shedding Research Operations and Making Money Selling Products https://www.wsj.com/articles/bid-for-allergan-puts-valeants-research-and-development-cuts-under-scrutiny-1402443053 https://www.wsj.com/articles/bid-for-allergan-puts-valeants-...